
Meatable NV raises US$10m in seed funding
BlueYard Capital, the Eurostars Programme of the European Commission, and angel VCs Taavet Hinrikus and Albert Wenger (Union Square Ventures)...

Researchers identify CTLA-4 response marker
The research team headed by Simon Heideger and Hendrick Poeck from Technical University of Munich together with colleagues from Memorial Sloan...

ADC Therapeutics set to go public
The number of shares to be offered and the price range for the proposed offering have still to be determined. Despite an internal review conducted...

2nd ECP Summer Summit at Henkel HQ, Düsseldorf
On September 26, international representatives from startups, SMEs, large companies. clusters, industry parks and further services providers came...

BIOncoTech Therapeutics and MSD combine cancer drugs
The clinical collaboration aims at providing clincial Phase II evidence that Bioncotech Therapeutics’ RNA–based cancer lead BO-112 can improve the...

bit bio restarts with new management
Cambridge-based cell reprogramming specialist Elpis Biomed will be re-started under the new name bit bio with a new management and an extended...

Evotec and Celmatix enter strategic partnership
Under the terms of the strategic R&D collaboration, Celmatix Inc. (New York) will utilise its proprietary multi-omics Reproductive Atlas platform...